 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jan 30, 2023 |
| Title |
Transcriptomics of AML core bone marrow biopsies reveals distinct therapy response-specific osteo-mesenchymal profiles by RNA-seq and microarray analysis |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
36354085 |
| Submission date |
Sep 12, 2022 |
| Last update date |
Jan 31, 2023 |
| Contact name |
Patrycja M Dubielecka |
| E-mail(s) |
patrycja_dubielecka-szczerba@brown.edu
|
| Organization name |
Warren Alpert Medical School of Brown University and Rhode Island Hospital
|
| Department |
Division of Hematology/Oncology, Department of Medicine
|
| Lab |
Dubielecka Lab
|
| Street address |
1 Hoppin St., Coro West, 5th Fl., Suite 5.36
|
| City |
Providence |
| State/province |
RI |
| ZIP/Postal code |
02903 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
| GPL23126 |
[Clariom_D_Human] Affymetrix Human Clariom D Assay [transcript (gene) version] |
|
| Samples (44)
|
| GSM6541569 |
bone marrow, NR13, 2nd |
| GSM6541570 |
bone marrow, NR2, 1st |
| GSM6541571 |
bone marrow, NR2, 2nd |
| GSM6541572 |
bone marrow, NR3, 1st |
| GSM6541573 |
bone marrow, NR3, 2nd |
| GSM6541574 |
bone marrow, NR9, 1st |
| GSM6541575 |
bone marrow, NR9, 2nd |
| GSM6541576 |
bone marrow, R1, 1st |
| GSM6541577 |
bone marrow, R1, 2nd |
| GSM6541578 |
bone marrow, R12, 1st |
| GSM6541579 |
bone marrow, R12, 2nd |
| GSM6541580 |
bone marrow, R14, 1st |
| GSM6541581 |
bone marrow, R14, 2nd |
| GSM6541582 |
bone marrow, R3, 1st |
| GSM6541583 |
bone marrow, R3, 2nd |
| GSM6541584 |
bone marrow, R5, 1st |
| GSM6541585 |
bone marrow, R5, 2nd |
| GSM6541586 |
bone marrow, R8, 1st |
| GSM6541587 |
bone marrow, R8, 2nd |
| GSM6570825 |
FFPE bone marrow, Responder Post-Treatment, biological rep2 |
| GSM6570826 |
FFPE bone marrow, Responder Post-Treatment, biological rep4 |
| GSM6570827 |
FFPE bone marrow, Responder Post-Treatment, biological rep1 |
| GSM6570828 |
FFPE bone marrow, Responder Post-Treatment, biological rep3 |
| GSM6570829 |
FFPE bone marrow, Responder Post-Treatment, biological rep5 |
| GSM6570830 |
FFPE bone marrow, Responder Post-Treatment, biological rep6 |
| GSM6570831 |
FFPE bone marrow, Non-Responder Post-Treatment, biological rep2 |
| GSM6570832 |
FFPE bone marrow, Non-Responder Post-Treatment, biological rep3 |
| GSM6570833 |
FFPE bone marrow, Non-Responder Post-Treatment, biological rep4 |
| GSM6570834 |
FFPE bone marrow, Non-Responder Post-Treatment, biological rep5 |
| GSM6570835 |
FFPE bone marrow, Non-Responder Post-Treatment, biological rep1 |
| GSM6570836 |
FFPE bone marrow, Responder Diagnosis, biological rep2 |
| GSM6570837 |
FFPE bone marrow, Responder Diagnosis, biological rep4 |
| GSM6570838 |
FFPE bone marrow, Responder Diagnosis, biological rep1 |
| GSM6570839 |
FFPE bone marrow, Responder Diagnosis, biological rep3 |
| GSM6570840 |
FFPE bone marrow, Responder Diagnosis, biological rep5 |
| GSM6570841 |
FFPE bone marrow, Responder Diagnosis, biological rep6 |
| GSM6570842 |
FFPE bone marrow, Non-Responder Diagnosis, biological rep2 |
| GSM6570843 |
FFPE bone marrow, Non-Responder Diagnosis, biological rep3 |
| GSM6570844 |
FFPE bone marrow, Non-Responder Diagnosis, biological rep4 |
| GSM6570845 |
FFPE bone marrow, Non-Responder Diagnosis, biological rep5 |
| GSM6570846 |
FFPE bone marrow, Non-Responder Diagnosis, biological rep1 |
|
| This SuperSeries is composed of the following SubSeries: |
| GSE212615 |
Transcriptomics of AML core bone marrow biopsies reveals distinct therapy response-specific osteo-mesenchymal profiles |
| GSE213056 |
Transcriptomics of AML core bone marrow biopsies reveals distinct therapy response-specific osteo-mesenchymal profiles [microarray] |
|
| Relations |
| BioProject |
PRJNA879746 |
|
|
|
|
 |
Less...
More...